Kragt J J, Thompson A J, Montalban X, Tintoré M, Río J, Polman C H, Uitdehaag B M J
VU University Medical Center, Department of Neurology, De Boelelaan 1117, PO Box 7057, 1007 MB Amsterdam, The Netherlands.
Neurology. 2008 Mar 25;70(13 Pt 2):1084-91. doi: 10.1212/01.wnl.0000288179.86056.e1. Epub 2008 Jan 9.
We studied the responsiveness and predictive value of two widely used clinical outcome measures that document multiple sclerosis (MS) disease progression-the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC)-in patients with primary progressive (PP) MS. Disease course in PPMS shows less fluctuation than in relapsing remitting (RR) MS.
In a group of 161 patients with PPMS, EDSS and MSFC were performed at three timepoints. To assess responsiveness, mean change scores and variances were plotted against baseline scores and effect sizes were calculated. Predictive value was determined by calculating sensitivity, specificity, and likelihood ratios (LRs) of 1-year changes to predict changes over 2 years. Furthermore, multivariate logistic regression models were used to assess the predictive value of short-term worsening on EDSS and MSFC.
Responsiveness of both EDSS and MSFC was shown to be limited and mean changes were highly dependent on the baseline scores. Effect sizes for EDSS and MSFC were small and inconclusive (0.239 and 0.161). The predictive value of a short-term worsening (baseline to year 1) to predict worsening in the long term (baseline to year 2) was expressed for EDSS by a sensitivity of 0.55 and a LR+ of 8.64. For MSFC, sensitivity was 0.68 and LR+ was 3.14. However, short-term worsening was a poor predictor of subsequent worsening (year 1 to year 2) for EDSS (LR+ 1.06) and this relationship was actually inverse for MSFC (LR+ 0.61).
In this study over a period of 2 years in primary progressive multiple sclerosis, the Multiple Sclerosis Functional Composite (MSFC) was less responsive than the Expanded Disability Status Scale (EDSS). The predictive value of neither EDSS nor MSFC was very powerful.
我们研究了两种广泛使用的记录多发性硬化症(MS)疾病进展的临床结局指标——扩展残疾状态量表(EDSS)和多发性硬化症功能综合评分(MSFC)——在原发性进行性(PP)MS患者中的反应性和预测价值。PPMS的病程波动比复发缓解型(RR)MS小。
在一组161例PPMS患者中,在三个时间点进行了EDSS和MSFC评估。为评估反应性,将平均变化分数和方差与基线分数作图,并计算效应量。通过计算1年变化的敏感性、特异性和似然比(LRs)来确定预测价值,以预测2年期间的变化。此外,使用多因素逻辑回归模型评估EDSS和MSFC短期恶化的预测价值。
EDSS和MSFC的反应性均有限,平均变化高度依赖于基线分数。EDSS和MSFC的效应量较小且无定论(分别为0.239和0.161)。短期恶化(基线至第1年)预测长期恶化(基线至第2年)的预测价值,EDSS的敏感性为0.55,阳性似然比为8.64。对于MSFC,敏感性为0.68,阳性似然比为3.14。然而,短期恶化对EDSS后续恶化(第1年至第2年)的预测能力较差(阳性似然比为1.06),而这种关系在MSFC中实际上是相反的(阳性似然比为0.61)。
在这项针对原发性进行性多发性硬化症为期2年的研究中,多发性硬化症功能综合评分(MSFC)的反应性低于扩展残疾状态量表(EDSS)。EDSS和MSFC的预测价值都不是很强。